Leap Therapeutics, Inc. has made headlines by securing nearly $6 million in a private investment deal, marking a significant step towards enhancing its digital asset strategy and clinical development, as emphasized in the official statement.
Leap Therapeutics Raises $5.888 Million in PIPE Transaction
On October 6, 2025, Leap Therapeutics announced that it has successfully raised $5.888 million through a private investment in public equity (PIPE) transaction. This funding will be instrumental in establishing a digital asset treasury strategy, which is expected to bolster the company's financial position and support its ongoing clinical pipeline initiatives.
Winklevoss Capital Leads Financing Round
Winklevoss Capital led the financing round and will also provide strategic counsel to the company as it navigates this new phase. The transaction is anticipated to close around October 8, 2025, and will bring about significant changes to Leap Therapeutics' governance structure, including an expansion of its Board of Directors to better align with its growth objectives.
